EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains

Freddy A Nunez iD, Ana C H Castro iD, Isabela P Daher iD, Edecio Cunha-Neto iD, Jorge Kalil, Silvia B Boscardin iD, Alexandre J C Lanfredi, Vivian L de Oliveira iD, Wendel A Alves iD

Biosensors · 2023

DOI: 10.3390/bios13030371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Freddy A Nunez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, São Paulo 09210-580, Brazil. Hauptthemen laut MEDLINE: Zinc Oxide, COVID-19, Vaccines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The evaluation of serological responses to COVID-19 is crucial for population-level surveillance, developing new vaccines, and evaluating the efficacy of different immunization programs. Research and development of point-of-care test technologies remain essential to improving immunity assessment, especially for SARS-CoV-2 variants that partially evade vaccine-induced immune responses. In this work, an impedimetric biosensor based on the immobilization of the recombinant trimeric wild-type spike protein (S protein) on zinc oxide nanorods (ZnONRs) was employed for serological evaluation. We successfully assessed its applicability using serum samples from spike-based COVID-19 vaccines: ChAdOx1-S (Oxford–AstraZeneca) and BNT162b2 (Pfizer–BioNTech). Overall, the ZnONRs/ spike-modified electrode displayed accurate results for both vaccines, showing excellent potential as a tool for assessing and monitoring seroprevalence in the population. A refined outcome of this technology was achieved when the ZnO immunosensor was functionalized with the S protein from the P.1 linage (Gamma variant). Serological responses against samples from vaccinated individuals were acquired with excellent performance. Following studies based on traditional serological tests, the ZnONRs/spike immunosensor data reveal that ChAdOx1-S vaccinated individuals present significantly less antibody-mediated immunity against the Gamma variant than the BNT162b2 vaccine, highlighting the great potential of this point-of-care technology for evaluating vaccine-induced humoral immunity against different SARS-CoV-2 strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc OxideCOVID-19VaccinesHumansBNT162 VaccineSARS-CoV-2COVID-19 VaccinesSeroepidemiologic StudiesAntibodiesAntibodies, Viral

Stichwörter der Autor:innen

BNT162b2 (Pfizer–BioNTech)COVID-19 vaccinesChAdOx1-S (Oxford–AstraZeneca)SARS-CoV-2antibody-mediated immunityelectrochemical immunosensorserological assessmentzinc oxide nanorods

Substanzen

Zinc OxideBNT162 VaccineCOVID-19 VaccinesAntibodiesVaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, São Paulo 09210-580, Brazil.
  • Laboratorio de Imunologia, INCOR, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo 05403-900, Brazil.
  • Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de Sao Paulo, São Paulo 05508-900, Brazil.
  • LIM-19, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo 05403-900, Brazil.
  • Centro de Engenharia, Modelagem e Ciências Sociais Aplicadas, Universidade Federal do ABC, São Paulo 09210-580, Brazil.

ORCID-Profile: Freddy A Nunez, Ana C H Castro, Isabela P Daher, Edecio Cunha-Neto, Silvia B Boscardin, Vivian L de Oliveira, Wendel A Alves

Förderung

  • São Paulo Research Foundation
  • National Council for Scientific and Technological Development
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • FAPESP
  • CNPq
  • CAPES

Zitieren

APA

Nunez, F. A., Castro, A. C. H., Daher, I. P., Cunha-Neto, E., Kalil, J., Boscardin, S. B., Lanfredi, A. J. C., Oliveira, V. L., & Alves, W. A. (2023). ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains. Biosensors. https://doi.org/10.3390/bios13030371

Vancouver

Nunez FA, Castro ACH, Daher IP, Cunha-Neto E, Kalil J, Boscardin SB, et al. ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains. Biosensors. 2023. doi:10.3390/bios13030371

BibTeX
@article{Nunez2023,
  author = {Nunez, Freddy A and Castro, Ana C H and Daher, Isabela P and Cunha-Neto, Edecio and Kalil, Jorge and Boscardin, Silvia B and Lanfredi, Alexandre J C and Oliveira, Vivian L de and Alves, Wendel A},
  title = {ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains},
  journal = {Biosensors},
  year = {2023},
  doi = {10.3390/bios13030371}
}
Kostenlos starten →